Klahr S, Levey A S, Beck G J, Caggiula A W, Hunsicker L, Kusek J W, Striker G
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.
N Engl J Med. 1994 Mar 31;330(13):877-84. doi: 10.1056/NEJM199403313301301.
Restricting protein intake and controlling hypertension delay the progression of renal disease in animals. We tested these interventions in 840 patients with various chronic renal diseases.
In study 1, 585 patients with glomerular filtration rates of 25 to 55 ml per minute per 1.73 m2 of body-surface area were randomly assigned to a usual-protein diet or a low-protein diet (1.3 or 0.58 g of protein per kilogram of body weight per day) and to a usual- or a low-blood-pressure group (mean arterial pressure, 107 or 92 mm Hg). In study 2, 255 patients with glomerular filtration rates of 13 to 24 ml per minute per 1.73 m2 were randomly assigned to the low-protein diet (0.58 g per kilogram per day) or a very-low-protein diet (0.28 g per kilogram per day) with a keto acid-amino acid supplement, and a usual- or a low-blood-pressure group (same values as those in study 1). An 18-to-45-month follow-up was planned, with monthly evaluations of the patients.
The mean follow-up was 2.2 years. In study 1, the projected mean decline in the glomerular filtration rate at three years did not differ significantly between the diet groups or between the blood-pressure groups. As compared with the usual-protein group and the usual-blood-pressure group, the low-protein group and the low-blood-pressure group had a more rapid decline in the glomerular filtration rate during the first four months after randomization and a slower decline thereafter. In study 2, the very-low-protein group had a marginally slower decline in the glomerular filtration rate than did the low-protein group (P = 0.07). There was no delay in the time to the occurrence of end-stage renal disease or death. In both studies, patients in the low-blood-pressure group who had more pronounced proteinuria at base line had a significantly slower rate of decline in the glomerular filtration rate.
Among patients with moderate renal insufficiency, the slower decline in renal function that started four months after the introduction of a low-protein diet suggests a small benefit of this dietary intervention. Among patients with more severe renal insufficiency, a very-low-protein diet, as compared with a low-protein diet, did not significantly slow the progression of renal disease.
限制蛋白质摄入和控制高血压可延缓动物肾脏疾病的进展。我们在840例各种慢性肾脏疾病患者中对这些干预措施进行了测试。
在研究1中,585例肾小球滤过率为每分钟每1.73平方米体表面积25至55毫升的患者被随机分配至正常蛋白饮食或低蛋白饮食组(每天每千克体重1.3克或0.58克蛋白质),以及正常血压或低血压组(平均动脉压分别为107或92毫米汞柱)。在研究2中,255例肾小球滤过率为每分钟每1.73平方米体表面积13至24毫升的患者被随机分配至低蛋白饮食组(每天每千克体重0.58克)或极低蛋白饮食组(每天每千克体重0.28克)并补充酮酸 - 氨基酸,以及正常血压或低血压组(与研究1中的数值相同)。计划进行18至45个月的随访,每月对患者进行评估。
平均随访时间为2.2年。在研究1中,饮食组之间或血压组之间在三年时肾小球滤过率的预计平均下降没有显著差异。与正常蛋白组和正常血压组相比,低蛋白组和低血压组在随机分组后的前四个月肾小球滤过率下降更快,此后下降更慢。在研究2中,极低蛋白组肾小球滤过率下降比低蛋白组略慢(P = 0.07)。终末期肾病或死亡发生时间没有延迟。在两项研究中,基线蛋白尿更明显的低血压组患者肾小球滤过率下降速率显著更慢。
在中度肾功能不全患者中,低蛋白饮食引入四个月后开始的肾功能下降较慢表明这种饮食干预有小的益处。在更严重肾功能不全的患者中,与低蛋白饮食相比,极低蛋白饮食并未显著减缓肾脏疾病的进展。